Anti-CD47 (magrolimab biosimilar) mAb
|Buffer||Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.|
|Guarantee||12 months from date of dispatch|
|Package||50 μg $80.00 ; 100 μg $160.00|
|Synonyms||CD47, MER6, IAP|
|Host Species||Chimeric Humanized|
|Purification||Purified from cell culture supernatant by affinity chromatography|
|Applications||ELISA, Flow Cyt|
|Recommended Dilutions||ELISA 1:5000-10000, Flow Cyt 1:100|
|Storage||Store at -20°C (Avoid repeated freezing and thawing)|
|Usage||Research use only|
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD47, mFc-His tagged protein (PME100008) can bind Anti-CD47 (Neutralizing antibody clone Hu5F9-G4) in a linear range of 0.061-1.606 ng/ml.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD47(A) were surface stained with anti-CD47 neutralizing antibody 1μg/ml (magrolimab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.
|Background||Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.|